Wootton, Robyn E.
Lawn, Rebecca B.
Magnus, Maria C.
Treur, Jorien L.
Corfield, Elizabeth C.
Njølstad, Pål R.
Andreassen, Ole A.
Lawlor, Deborah A.
Munafò, Marcus R.
Håberg, Siri E.
Davey Smith, George
Reichborn-Kjennerud, Ted
Magnus, Per
Havdahl, Alexandra
Funding for this research was provided by:
Helse Sør-Øst RHF (2020024, 2020022)
Norges Forskningsråd (300668, 288083, 274611, 274611, 262700, 320656, #229624, #223273, 262700, 262700)
Medical Research Council (MM_UU_00011/1, MM_UU_00011/7)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.Veni.195.016)
National Institute of Mental Health and Neurosciences (R01 MH101269)
HORIZON EUROPE European Research Council (947684)
Horizon 2020 Framework Programme (101021566)
Norwegian Institute of Public Health
Article History
Received: 28 March 2022
Accepted: 13 March 2023
First Online: 3 April 2023
Declarations
:
: The establishment of MoBa and initial data collection was based on a license from the Norwegian Data Protection Agency and approval from The Regional Committees for Medical and Health Research Ethics. The MoBa cohort is now based on regulations related to the Norwegian Health Registry Act. The current study was approved by The Regional Committees for Medical and Health Research Ethics (2016/1702). Participants of the Norwegian Mother, Father and Child Cohort Study have consented to participate.
: Participants of the Norwegian Mother, Father and Child Cohort Study have consented for results to be published as part of the MoBa consent procedure. This publication has adhered to the MoBa publication checklist and obtained permission to publish.
: DAL acknowledges support from Roche Diagnostics and Medtronic Ltd in the last 10 years for research unrelated to that presented here. DAL is an editor for BMC-Medicine. The other authors declare no competing interests.